KOC
TMO icon

Koss-Olinger Consulting’s Thermo Fisher Scientific TMO Stock Holding History

Koss-Olinger Consulting’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-359
Closed -$208K – 285
2025
Q4 		$208K Sell
359
-280
-44% -$158K 0.02% 261
2025
Q3 		$259K Hold
639
– – 0.02% 276
2025
Q2 		$259K Sell
639
-23
-3% -$9.62K 0.02% 280
2025
Q1 		$329K Buy
+662
New +$359K 0.03% 248
2024
Q4 		– Sell
-531
Closed -$328K – 275
2024
Q3 		$328K Hold
531
– – 0.03% 216
2024
Q2 		$294K Buy
+531
New +$304K 0.03% 213
2024
Q1 		– Sell
-576
Closed -$306K – 281
2023
Q4 		$306K Buy
576
+11
+2% +$5.32K 0.03% 235
2023
Q3 		$286K Sell
565
-10
-2% -$5.33K 0.04% 196
2023
Q2 		$300K Hold
575
– – 0.03% 185
2023
Q1 		$331K Sell
575
-4
-0.7% -$2.25K 0.04% 166
2022
Q4 		$319K Sell
579
-22
-4% -$11.7K 0.05% 155
2022
Q3 		$305K Buy
601
+85
+16% +$47.6K 0.05% 152
2022
Q2 		$280K Sell
516
-77
-13% -$42.4K 0.05% 138
2022
Q1 		$350K Sell
593
-101
-15% -$58K 0.06% 137
2021
Q4 		$463K Sell
694
-58
-8% -$36.2K 0.07% 118
2021
Q3 		$430K Sell
752
-48
-6% -$26.3K 0.07% 129
2021
Q2 		$404K Buy
800
+53
+7% +$25K 0.06% 160
2021
Q1 		$341K Buy
+747
New +$357K 0.06% 163

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Koss-Olinger Consulting's TMO Position: Q1 2026 in Review

Koss-Olinger Consulting sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 359 shares — an estimated $208K sold.

Koss-Olinger Consulting first reported a position in TMO in Q1 2021 and held it in 18 quarters. The position peaked at $463K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Koss-Olinger Consulting reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Koss-Olinger Consulting sold 359 Thermo Fisher Scientific shares in Q1 2026, an estimated $208K.
  • Koss-Olinger Consulting first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 18 quarters.
  • Koss-Olinger Consulting's Thermo Fisher Scientific position peaked at $463K in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.